Travere Therapeutics Inc. (TVTX)
19.75
-1.65 (-7.71%)
At close: Mar 03, 2025, 3:59 PM
19.80
0.28%
After-hours: Mar 03, 2025, 04:05 PM EST
Travere Therapeutics Balance Sheet Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
Cash & Equivalents | 58.53M | 58.18M | 61.69M | 165.75M | 84.77M | 62.44M | 102.87M | 99.39M | 41M | 37.8M | 18.2M | 6M | 11.39K | 3.91K | 3.96K | n/a | 4.77K |
Short-Term Investments | 312.17M | 508.68M | 388.56M | 387.13M | 276.82M | 336.09M | 368.67M | 201.24M | 214.87M | 191.8M | 9.56M | 132.99K | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | 15M | -16.81M | -6.42M | 21.25M | -140.81M | -2.6B | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 53.82M | 42.16M | 11.06M | 11.07M | 33.49M | 14.71M | -25M | 5.56M | 7.36M | 2M | 1.93M | 40K | 137.55K | n/a | n/a | n/a | n/a |
Receivables | 27.12M | 21.18M | 16.65M | 15.91M | 33.07M | 18.05M | 14.49M | 13.87M | 65.36M | 59.31M | 7.96M | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | 6.2M | 9.41M | 6.92M | 7.31M | 7.61M | 6.08M | 5.62M | 5.35M | 2.83M | 2.54M | 800.51K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 12.69M | 19.34M | 15.02M | 6.72M | 8.14M | 7.8M | 4.03M | 8.8M | 8.29M | 10.48M | 813.36K | 1.37M | 21.83K | n/a | n/a | n/a | n/a |
Total Current Assets | 416.7M | 616.77M | 486.44M | 582.83M | 410.41M | 429.06M | 495.68M | 325.81M | 332.35M | 301.93M | 37.33M | 7.5M | 33.22K | 3.91K | 3.96K | n/a | 4.77K |
Property-Plant & Equipment | 19.63M | 25.54M | 30.05M | 34.3M | 9.42M | 2.89M | 3.15M | 3.23M | 2.59M | 428K | 670.8K | 127.43K | 23.79K | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | 103.97M | 104.44M | 145.04M | 148.44M | 154.13M | 158.14M | 187.63M | 185.75M | 182.98M | 162.47M | 95.2M | 12.59M | 2.2M | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 177.42M | 172.14M | 186.15M | 193.81M | 197.03M | 175.74M | 213.48M | 194.54M | 192.93M | 210.47M | 98.14M | 13M | 2.36M | n/a | n/a | n/a | n/a |
Total Assets | 594.13M | 788.91M | 672.59M | 776.63M | 607.44M | 604.8M | 709.16M | 520.35M | 525.28M | 512.4M | 135.47M | 20.5M | 2.39M | 3.91K | 3.96K | n/a | 4.77K |
Account Payables | 23.53M | 41.67M | 17.29M | 15.14M | 12.13M | 26.61M | 6.95M | 18.94M | 7.52M | 7.64M | 7.12M | 3.55M | 1.02M | 750.00 | 750.00 | n/a | 750.00 |
Deferred Revenue | 2.81M | 7.1M | 11.98M | 16.27M | -357K | -2.61M | 49.7M | n/a | n/a | n/a | 28.88M | n/a | 2.49M | n/a | n/a | n/a | n/a |
Short-Term Debt | 74.08M | 4.91M | 8.87M | 7.82M | 357K | n/a | 22.46M | n/a | n/a | n/a | 40.49M | n/a | 884.76K | 25K | 25K | n/a | 4.17K |
Other Current Liabilities | 100.32M | 124.23M | 104.03M | 84.86M | 80.17M | 68.83M | 75.21M | 66.73M | 75.74M | 79.34M | 59.93M | 33.01M | 3.89M | 41.24K | 38.46K | n/a | 28.94K |
Total Current Liabilities | 200.75M | 177.91M | 142.16M | 124.09M | 92.66M | 95.45M | 104.62M | 85.67M | 83.26M | 85.8M | 107.54M | 35.21M | 5.8M | 66.99K | 64.21K | n/a | 33.86K |
Long-Term Debt | 327.5M | 399.88M | 430.56M | 258.08M | 243.68M | 204.86M | 195.09M | 45.08M | 44.42M | 43.77M | 43.29M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 6.8M | 8.48M | 46.08M | 71.98M | 59.89M | 83.29M | 91.19M | 96.47M | 83.41M | 81.55M | 21.9M | 1M | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 334.3M | 410.19M | 487.57M | 350.43M | 303.57M | 288.15M | 286.29M | 141.54M | 134.25M | 126.63M | 65.18M | 3.6M | 1.91M | n/a | 25.75K | n/a | n/a |
Total Liabilities | 535.05M | 588.1M | 629.73M | 474.52M | 396.23M | 383.6M | 390.91M | 227.21M | 217.51M | 212.43M | 172.72M | 38.81M | 5.8M | 66.99K | 64.21K | n/a | 33.86K |
Total Debt | 401.58M | 404.78M | 407.49M | 261.99M | 215.34M | 204.86M | 217.55M | 45.08M | 44.42M | 43.9M | 83.77M | n/a | 884.76K | 25K | 25K | n/a | 4.17K |
Common Stock | 9K | 7K | 6K | 6K | 5K | 4K | 4K | 4K | 4K | 4K | 2.64K | 1.85K | 895.00 | 11.00 | 11.00 | n/a | n/a |
Retained Earnings | -1.45B | -1.13B | -1.01B | -765.97M | -585.88M | -416.44M | -270.02M | -177.66M | -113.06M | -65.15M | -179.17M | -67.44M | -33.61M | -136.08K | -121.26K | n/a | -70.26K |
Comprehensive Income | -80K | -1.46M | -2.91M | -562K | -902K | 726K | -1.53M | -1.01M | -490K | -682K | 4.29M | -109.99K | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 59.08M | 200.81M | 42.85M | 302.11M | 211.21M | 221.2M | 318.25M | 293.13M | 307.77M | 299.97M | -37.25M | -18.31M | -3.41M | -63.08K | -60.26K | n/a | 1.00 |
Total Investments | 312.17M | 508.68M | 388.56M | 387.13M | 276.82M | 336.09M | 383.67M | 201.24M | 214.87M | 191.8M | 9.56M | 132.99K | n/a | n/a | n/a | n/a | n/a |